Effect of serotypes on clinical manifestations of dengue fever in adults.
暂无分享,去创建一个
Shu-Hui Lin | Chun-Yu Lin | Yen-Hsu Chen | Chien-Chou Lin | Jyh-Hsiung Huang | W. Lin | P. Lu | K. S. Chan | Jung-San Chang | J. Tsai | Ko Chang | Tun-Chieh Chen | Hsiao-Chen Hsieh | J. Lin | Jyh‐Hsiung Huang | Weizhi Lin | Weizhi Lin
[1] R. He,et al. Antibody-enhanced binding of dengue-2 virus to human platelets. , 1995, Virology.
[2] P. Glaziou,et al. Correlation between detection of plasminogen cross-reactive antibodies and hemorrhage in dengue virus infection. , 1994, The Journal of infectious diseases.
[3] S. Halstead. Is there an inapparent dengue explosion? , 1999, The Lancet.
[4] M. Tsai,et al. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity , 2008, Nature Reviews Immunology.
[5] Ko Yc. Epidemiology of dengue fever in Taiwan , 1989 .
[6] A. Nisalak,et al. A prospective study of dengue infections in Bangkok. , 1988, The American journal of tropical medicine and hygiene.
[7] S. Halstead,et al. Epidemiologic studies on Dengue in Santiago de Cuba, 1997. , 2000, American journal of epidemiology.
[8] A. Nisalak,et al. Dengue in the early febrile phase: viremia and antibody responses. , 1997, The Journal of infectious diseases.
[9] Ting-Hsiang Lin,et al. Comparison of Capture Immunoglobulin M (IgM) and IgG Enzyme-Linked Immunosorbent Assay (ELISA) and Nonstructural Protein NS1 Serotype-Specific IgG ELISA for Differentiation of Primary and Secondary Dengue Virus Infections , 2003, Clinical Diagnostic Laboratory Immunology.
[10] L. Rosen,et al. Recovery of virus from the liver of children with fatal dengue: reflections on the pathogenesis of the disease and its possible analogy with that of yellow fever. , 1989, Research in virology.
[11] W. J. McBride,et al. Dengue viral infections; pathogenesis and epidemiology. , 2000, Microbes and infection.
[12] J. Schlesinger,et al. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells , 2008, Journal of medical virology.
[13] S. Kalayanarooj,et al. Clinical and Laboratory Presentations of Dengue Patients with Different Serotypes , 2000 .
[14] M. Guzmán,et al. Description of the clinical picture of dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) in adults. , 1988, Bulletin of the Pan American Health Organization.
[15] Yee‐Shin Lin,et al. Generation of IgM anti‐platelet autoantibody in dengue patients , 2001, Journal of medical virology.
[16] P. Shu,et al. Laboratory-based dengue surveillance in Taiwan, 2005: a molecular epidemiologic study. , 2007, The American journal of tropical medicine and hygiene.
[17] M. Guzmán. Deciphering Dengue: The Cuban Experience , 2005, Science.
[18] M. Guzmán,et al. Dengue: an update. , 2002, The Lancet. Infectious diseases.
[19] Halstead Sb,et al. Dengue: hematologic aspects. , 1982 .
[20] Y. Ko. [Epidemiology of dengue fever in Taiwan]. , 1989, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences.
[21] Robert Anderson,et al. Dengue Virus Selectively Induces Human Mast Cell Chemokine Production , 2002, Journal of Virology.
[22] J. Stephenson. Understanding dengue pathogenesis: implications for vaccine design. , 2005, Bulletin of the World Health Organization.
[23] Tyen‐Po Chen,et al. Clinical characteristics of dengue and dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic. , 2006, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[24] M. Guzmán,et al. Clinical and serologic study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). , 1987, Bulletin of the Pan American Health Organization.
[25] Chung-Te Chang,et al. Status of Dengue Control Programme in Taiwan − 2001 , 2002 .
[26] M. Shaio,et al. Production of cytokines and platelet activating factor in secondary dengue virus infections. , 1995, The Journal of infectious diseases.